ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jun 29, 2018
Dividend Increases/Decreases for the Week Ending June 29
Let's take a look at companies that raised/lowered their dividend this week.
Jun 28, 2018
Amazon: The Destroyer of Other Companies’ Profits
Image Source: Victor. Amazon is stepping into the pharmacy business with the purchase of online pharmacy start-up PillPack. The market is implying the move will prove to be more than just a headache for those operating in the drug store/pharmacy and drug-distributor complex. Whether the impact will be significantly material in the coming years remains to be seen, but it’s a big directional negative for impacted parties.
Jun 27, 2018
Roche Continues to Underwhelm
We like cutting-edge, novel therapies as they have a transformative impact on a small to mid-cap biotech as years of revenue growth could be in the cards. While new therapies are the life-blood of the research field, the impact of a new novel therapy on the growth prospects of a large cap is often muted, however. Such is the fate of Roche as it struggles to replace its mainstay oncology division with new patent-protected entities.
Jun 27, 2018
Restaurant Traffic Down, Chipotle Still a Favorite Idea
Image Source: Chipotle (page 89 of 160). In late April of this year, we added Chipotle to the simulated Best Ideas Newsletter portfolio. The high end of our fair value estimate is nearly $600.
Jun 26, 2018
Requesting Your Comments on Our Letter Regarding Proposed Rule: Regulation Best Interest
Valuentum takes its role as an independent financial publisher seriously. Recently-proposed rules by the SEC can have serious implications on the retirement accounts of millions of Americans. We ask for your opinion regarding our comment letter to the SEC, which we have not yet submitted, pending feedback from our members.
Jun 26, 2018
General Electric Stripping Businesses, Dividend in Aggregate
Image source: GE investor presentation. Once a seemingly unshakable component of the Dow Jones Industrial Average and one of the most-recognizable industrial firms in the world, General Electric announced further divestiture plans of its sprawling portfolio of businesses. More changes are in store for its dividend as well.
Jun 26, 2018
Eli Lilly Looks to Bolster Its Presence in Oncology
We are becoming increasingly impressed with Eli Lilly as the company boasts an enviable stable of new products that should power the company well into the next decade. Lilly is through the bulk of its patent trough, in our view, and its pipeline should set the company up for years of potentially uninterrupted revenue growth. Shares are not necessarily cheap, however.
Jun 25, 2018
Still Expecting Strong 2018 from Digital Realty
Image Source: DLR Investor Presentation. In April of this year, we added Digital Realty Trust to the simulated Dividend Growth Newsletter portfolio. We think its addition adds a nice boost to the overall dividend yield to the portfolio.
Jun 24, 2018
Aiding in Misbehaving
Download the full paper in this article.
Jun 24, 2018
Owens & Minor: Dividend At Risk, But Shares Not Expensive
We’re fans of consistent dividend payers with strong free-cash-flow coverage and solid balance sheets, but we remain very skeptical of companies with a dividend that seems “too good to be true” as the eye-popping dividend is often a byproduct of an egregious drop in the price of the stock. We believe Owens & Minor is an example of an overleveraged, slow-growth entity that may have trouble maintaining its dividend in coming years. We value shares at $20 each, however, so the market may be overreacting a bit on the downside.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.